ReviewCureus2025
Advancing Health Equity Through Telepharmacy Antimicrobial Stewardship in Rural Communities in the United States.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance remains a growing global threat, disproportionately impacting underserved rural communities in the United States with limited access to pharmacy services. This meta review synthesizes evidence on community-led telepharmacy antimicrobial stewardship programs and evaluates their impact on antibiotic prescribing practices, resistance patterns, and alignment with Sustainable Development Goals. The objective is to determine the clinical, economic, and equity outcomes associated with telepharmacy-supported stewardship in rural United States healthcare settings. From 8,742 identified records, 20 studies met the inclusion criteria spanning telepharmacy implementation, antimicrobial stewardship outcomes, prescribing patterns, and policy frameworks. Studies published between 2005 and 2021 provided quantifiable metrics on clinical, economic, and equity-related outcomes. Inappropriate antibiotic use decreased by 28.6% (95% CI 21.3 to 35.9, p<0.001), and odds of appropriate prescribing improved significantly (OR 3.21, 95% CI 2.54 to 4.06). Broad spectrum utilization declined by 32.4%, guideline concordant selection improved by 41.2%, medication errors decreased by 94% (OR 0.06, 95 percent CI 0.03 to 0.12), and antibiotic de-escalation rates nearly doubled (34% to 67%). Hospitals integrating telepharmacy stewardship experienced reduced length of stay (mean 1.8 days, 95% CI 1.2 to 2.4, p<0.001) and 41% fewer Clostridium difficile infections (IRR 0.59, 95 percent CI 0.43 to 0.81). Days of therapy per 1,000 patient days decreased by 89.7 days (95% CI 67.2 to 112.3). Programs demonstrated cost savings of 3.45 dollars per dollar invested (95% CI 2.89 to 4.01). Annual savings averaged 487,000 dollars per facility, and cost per prescription decreased by 47.30 dollars. Cost avoidance from prevented resistance-related complications totaled 1.2 million dollars annually per 200-bed facility. Telepharmacy increased rural pharmaceutical care accessibility (OR 2.71, 95% CI 2.03 to 3.62, p<0.001). Preventive service use increased by 23.4%, and equity index scores improved by 18.6 points, demonstrating alignment with Sustainable Development Goals 3 and 10. Program retention reached 83.4% at two years, with provider acceptance of 89.7% and improved staff satisfaction (mean increase 2.2 points, p<0.001). Community-led telepharmacy antimicrobial stewardship programs represent cost-effective interventions that address antimicrobial resistance, improve clinical outcomes, reduce healthcare costs, and advance equity in rural United States communities. Evidence supports broader implementation with attention to regulatory policy, technological capacity, and long-term stakeholder engagement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.